At a glance

ClinicalIndex Comparison Record

N/ACompleted· 100 enrolled

Drug / intervention

150% Oral Morphine Equivalent (OME) +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01447888

NCT01447888N/ACompleted

Compare CT.gov

Perioperative Pain Management In Spine Surgery Patients: Part I

Allina Health System·interventional·Posted Oct 6, 2011·Updated Apr 27, 2020

In Brief

A clinical study evaluating 150% Oral Morphine Equivalent (OME) and Clinical Judgment for Pain. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is a comparison of pain management in opioid-tolerant spine surgery patients using a perioperative dosing goal of 150% of patient's baseline oral morphine equivalent (OME), as compared to standard perioperative dosing, which does not currently account for patients' baseline opiate use.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsPain

CountriesUnited States

Collaborators--

Timeline

N/ACompletedFinished

201220132014201520162017201820192020202120222023202420252026

Enrollment StartSep 2011

First PostedOct 2011

Primary CompletionMar 2014

Study CompletionApr 2014

TodayJul 2026

First PostedOct 6, 2011

Enrollment StartSep 1, 2011

Primary CompletionMar 1, 2014

Study CompletionApr 1, 2014

TodayJul 2, 2026

Enrollment to primary: 2.5 yearsPosted 14.7 years ago

Interventions

150% Oral Morphine Equivalent (OME)drug

Patients will receive 150% of their oral morphine equivalent (OME) utilizing the drugs Dilaudid and Fentanyl.

Clinical Judgmentother

This method of perioperative parenteral opioid dosing has been used on spine surgery patients, based on clinical decision of the anesthesiologist.